SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001387131-20-006953
Filing Date
2020-08-03
Accepted
2020-07-31 17:39:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP pand-sc13d_072120.htm SC 13D 105242
2 LOCK-UP AGREEMENT, DATED AS OF MAY 19, 2020 ex-2.htm EX-2 39633
  Complete submission text file 0001387131-20-006953.txt   146527
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Subject) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91578 | Film No.: 201067097
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences